Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders: A Randomized Controlled Superiority Trial

NCT06937892 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06937892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06937892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders: A Randomized Controlled Superiority Trial
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Recruiting
Start date
August 27, 2025
Completion date
December 31, 2028
Enrollment
86 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

generalized anxiety disorder (gad), posttraumatic stress disorder (ptsd), social anxiety disorder (sad)